How should I adjust the fluoxetine (Prozac) and bupropion (Wellbutrin) regimen for a patient with OCD who is experiencing worsening obsessive thoughts while on fluoxetine 20 mg and bupropion 300 mg?

Increase Fluoxetine Dose to 40-60 mg Daily

Your patient is on a subtherapeutic dose of fluoxetine for OCD and requires dose escalation; bupropion should be discontinued as it has no evidence for OCD and may worsen obsessive symptoms.

Primary Recommendation: Optimize SSRI Dosing

The current fluoxetine dose of 20 mg is inadequate for OCD treatment. According to FDA labeling and treatment guidelines, OCD requires higher SSRI doses than depression 1. The evidence-based approach is:

• Increase fluoxetine to 40-60 mg daily (FDA-approved range for OCD is 20-80 mg, with 60 mg showing superior efficacy) 1
• The full therapeutic effect may be delayed until 5 weeks of treatment or longer at the target dose 1
• In controlled trials, only the 60 mg dose showed statistically significant superiority over lower doses in some studies 2

Critical Issue: Discontinue Bupropion

Bupropion has no established efficacy for OCD and may be contributing to symptom worsening:

• A 2005 open-label study found bupropion had no mean effect on OCD symptoms, with 8 of 12 patients experiencing symptom exacerbation (mean 21% increase in Y-BOCS) 3
• Case reports document new-onset obsessive-compulsive symptoms associated with bupropion treatment that resolved upon discontinuation 4
• Bupropion is not mentioned in any OCD treatment guidelines as a therapeutic option 5

Evidence-Based Treatment Algorithm for Inadequate SSRI Response

According to 2019 Nature Reviews Disease Primers guidelines 5:

First-line strategies when SSRI monotherapy fails:

1. Increase SSRI dose to maximum recommended or tolerated (fluoxetine up to 80 mg) - this is your current step
2. Add CBT with exposure and response prevention (ERP) - effect sizes are larger with SSRI + CBT augmentation than with antipsychotic augmentation 5
3. Allow adequate trial duration: 8-12 weeks at maximum dose 5

Second-line strategies if inadequate response persists:

1. Switch to different SSRI or clomipramine 5
2. Augment with antipsychotics (risperidone or aripiprazole have best evidence, though only one-third achieve meaningful response) 5
3. Augment with glutamatergic agents (N-acetylcysteine has largest evidence base; memantine also supported) 5

Common Pitfalls to Avoid

• Underdosing SSRIs: The 20 mg fluoxetine dose appropriate for depression is typically insufficient for OCD 5
• Premature discontinuation: Approximately half of patients fail to fully respond to first-line treatment, but continued optimization is warranted 5
• Using non-evidence-based augmentation: Bupropion lacks any controlled trial evidence for OCD and may worsen symptoms 3, 4
• Inadequate trial duration: Early improvement (by 2-4 weeks) predicts response, but full effect requires 5+ weeks at therapeutic dose 5

Practical Implementation

Immediate steps:

• Taper and discontinue bupropion (no therapeutic benefit for OCD)
• Increase fluoxetine to 40 mg daily for 2-3 weeks, then to 60 mg if tolerated
• Monitor for dose-related adverse effects (GI symptoms, sexual dysfunction, activation)
• Refer for CBT with ERP if not already engaged

Timeline expectations:

• Assess response at 8-12 weeks on optimized dose (60 mg) 5
• If inadequate response, consider switching SSRIs or evidence-based augmentation strategies
• Maintenance treatment should continue 12-24 months minimum after achieving remission 5

The evidence strongly supports that your patient needs proper SSRI optimization before considering augmentation strategies, and bupropion should be removed from the regimen as it provides no benefit and potential harm for OCD symptoms.